Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...

Amgen posted a higher quarterly profit on Tuesday, driven by an 11% rise in product sales, and said late-stage studies of key ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Biogen expects revenue from new launches to exceed its current sales by 2028 and does not feel the need to chase additional ...

Pharma Digs in on Changes It Wants From Trump Administration By Deena Beasley SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices ...

SAN FRANCISCO, Jan 14 (Reuters) - The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's ...

SAN FRANCISCO (Reuters) - The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's priorities ...

By Deena Beasley (Reuters) - Amgen Inc (O:AMGN) on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential ...

By Deena Beasley (Reuters) - Two prominent U.S. lawmakers on Thursday called on federal antitrust regulators to probe whether Sanofi (PA:SASY) SA, Eli Lilly and Co, Merck ...